6-[4-(benzenesulfonyl)-3-[2-[1-(trifluoromethyl)cyclopropyl]ethoxy]pyrazol-1-yl]pyridine-3-carboxamide
C21H19F3N4O4S — CID 153410276
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-[4-(benzenesulfonyl)-3-[2-[1-(trifluoromethyl)cyclopropyl]ethoxy]pyrazol-1-yl]pyridine-3-carboxamide
6-[4-(benzenesulfonyl)-3-[2-[1-(trifluoromethyl)cyclopropyl]ethoxy]pyrazol-1-yl]pyridine-3-carboxamide (PubChem CID 153410276) has the molecular formula C21H19F3N4O4S and a molecular weight of 480.47 g/mol. Its IUPAC name is 6-[4-(benzenesulfonyl)-3-[2-[1-(trifluoromethyl)cyclopropyl]ethoxy]pyrazol-1-yl]pyridine-3-carboxamide.
Molecular Properties
| Compound Name | 6-[4-(benzenesulfonyl)-3-[2-[1-(trifluoromethyl)cyclopropyl]ethoxy]pyrazol-1-yl]pyridine-3-carboxamide |
|---|---|
| PubChem CID | 153410276 |
| Molecular Formula | C21H19F3N4O4S |
| Molecular Weight | 480.47 g/mol |
| Exact Mass | 480.11 |
| IUPAC Name | 6-[4-(benzenesulfonyl)-3-[2-[1-(trifluoromethyl)cyclopropyl]ethoxy]pyrazol-1-yl]pyridine-3-carboxamide |
| SMILES | NC(=O)c1ccc(-n2cc(S(=O)(=O)c3ccccc3)c(OCCC3(C(F)(F)F)CC3)n2)nc1 |
| InChI | InChI=1S/C21H19F3N4O4S/c22-21(23,24)20(8-9-20)10-11-32-19-16(33(30,31)15-4-2-1-3-5-15)13-28(27-19)17-7-6-14(12-26-17)18(25)29/h1-7,12-13H,8-11H2,(H2,25,29) |
| InChIKey | JDNSEPDXDBHBJQ-UHFFFAOYSA-N |
| XLogP | 3.31 |
| TPSA | 117.17 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 480.47 |
| LogP ≤ 5 | 3.31 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 153410276 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.